Detalhe da pesquisa
1.
Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination.
J Infect Dis
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682569
2.
Antibodies Produced in Response to a Live-Attenuated Dengue Vaccine Are Functional in Activating the Complement System.
J Infect Dis
; 227(11): 1282-1292, 2023 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36461942
3.
Molecular characterization of measles viruses in Central African Republic, 2012-2016.
J Med Virol
; 95(8): e29003, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37537927
4.
Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination.
J Infect Dis
; 225(9): 1521-1532, 2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33319249
5.
Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003).
Clin Infect Dis
; 75(1): 107-117, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34606595
6.
Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial.
Lancet
; 395(10234): 1434-1443, 2020 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32197107
7.
Hepatitis E virus outbreak associated with rainfall in the Central African Republic in 2008-2009.
BMC Infect Dis
; 20(1): 260, 2020 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32245368
8.
Tetravalent Dengue Vaccine in Healthy Children. Reply.
N Engl J Med
; 382(18): 1770-1771, 2020 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32348660
9.
IgG, IgM, and Nonstructural Protein 1 Response Profiles after Receipt of Tetravalent Dengue Vaccine TAK-003 in a Phase 2 Randomized Controlled Trial.
Am J Trop Med Hyg
; 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38806045
10.
Investigating animal reservoirs for hepatitis E virus in Bangui, Central African Republic.
PLoS One
; 19(3): e0300608, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489313
11.
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Glob Health
; 12(2): e257-e270, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38245116
12.
High-resolution analysis of intrahost genetic diversity in dengue virus serotype 1 infection identifies mixed infections.
J Virol
; 86(2): 835-43, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22090119
13.
First introduction of pandemic influenza A/H1N1 and detection of respiratory viruses in pediatric patients in Central African Republic.
Virol J
; 10: 49, 2013 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23391188
14.
Measles outbreak in Northern Central African Republic 3 years after the last national immunization campaign.
BMC Infect Dis
; 13: 103, 2013 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23442214
15.
A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country.
Vaccine
; 41(7): 1398-1407, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681529
16.
Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.
PLoS Negl Trop Dis
; 17(3): e0011124, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36888687
17.
Consistency of immunogenicity in three consecutive lots of a tetravalent dengue vaccine candidate (TAK-003): A randomized placebo-controlled trial in US adults.
Vaccine
; 41(47): 6999-7006, 2023 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37884415
18.
Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults.
NPJ Vaccines
; 8(1): 75, 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37230978
19.
Characterization of the cell-mediated immune response to Takeda's live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting.
Vaccine
; 40(8): 1143-1151, 2022 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078666
20.
Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses.
BMC Infect Dis
; 10: 142, 2010 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-20509940